Skip to content

Drug interactions

Golimumab + Trastuzumab deruxtecan

Severity: Moderate

Golimumab and Trastuzumab deruxtecan: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Trastuzumab deruxtecan can cause neutropenia and febrile neutropenia, and golimumab impairs host defence against infection. Combined use may raise the risk and severity of infections.

What this interaction means in plain words

Golimumab and Trastuzumab deruxtecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Golimumab belongs to Musculoskeletal; Trastuzumab deruxtecan belongs to Oncology.

Evidence level: Low

Why it happens

Additive effects of chemotherapy-related myelosuppression and TNF-blocker immunosuppression.

What to do

Monitor complete blood counts and for infection signs. Consider holding golimumab during significant neutropenia or active infection.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Golimumab and Trastuzumab deruxtecan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Golimumab with Trastuzumab deruxtecan?

MediHelp rates the interaction as moderate. Golimumab and Trastuzumab deruxtecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Trastuzumab deruxtecan can cause neutropenia and febrile neutropenia, and golimumab impairs host defence against infection. Combined use may raise the risk and severity of infections.

How serious is the interaction between Golimumab and Trastuzumab deruxtecan?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor complete blood counts and for infection signs. Consider holding golimumab during significant neutropenia or active infection.

What other medicines interact with Golimumab?

MediHelp also lists interactions of Golimumab with, for example, Bcg vaccine live, Etanercept, Influenza virus vaccine quadrivalent intranasal. The full list is on the Golimumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in